Continuing efficacy of milnacipran following long-term treatment in fibromyalgia: a randomized trial
2013
Introduction
Previous studies of long-term treatment response in fibromyalgia and other chronic pain states have generally been limited to approximately one year, leaving questions about the longer-term durability of response. The purpose of this study was to demonstrate continuing efficacy of milnacipran by characterizing changes in pain and other fibromyalgia symptoms after discontinuing long-term treatment. The mean length of milnacipran treatment at the time of randomized withdrawal was 36.1 months from initial exposure to milnacipran (range, 17.9 to 54.4 months).
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
37
References
10
Citations
NaN
KQI